Association Between Pulmonary Function and Sputum Biomarkers in Cystic Fibrosis

Overview

Journal Am J Respir Crit Care Med

Specialty Critical Care

Date 2007 Jan 20

PMID 17234902

Citations 96

Authors

Nicole Mayer-Hamblett

Moira L Aitken

Frank J Accurso

Richard A Kronmal

Michael W Konstan

Jane L Burns

Scott D Sagel

Bonnie W Ramsey

Affiliations

Soon will be listed here.

Abstract

Rationale: Sputum biomarkers of infection and inflammation are noninvasive measures that enable quantification of the complex pathophysiology of cystic fibrosis (CF) lung disease. Validation of these biomarkers as correlates of disease severity is a key step for their application.

Objectives: We constructed a large database from four multicenter studies to quantify the strength of association between expectorated sputum biomarkers and FEV(1.)

Methods: FEV(1) (range, 25-120% predicted) and quantitative data on expectorated sputum biomarkers including free neutrophil elastase, IL-8, neutrophils, Pseudomonas aeruginosa, and Staphylococcus aureus were obtained from 269 participants (ages, 9-54 years) from 33 centers. Cross-sectional and longitudinal statistical analyses were performed to estimate associations between the markers and FEV(1), including the use of multivariable analyses.

Results: Elastase was negatively correlated with FEV(1) (correlation [r] = -0.35; 95% confidence interval [CI]: -0.46, -0.22). On average, patients with CF who differed in their elastase measurements by 0.5 log differed in their FEV(1) values by -7.3% (95% CI: -9.7, -4.6). Neutrophil counts and IL-8 were also each negatively correlated. In a multivariable regression, elastase and neutrophil counts were able to explain the majority of variation in FEV(1). Elastase was further shown to have a significant longitudinal association with FEV(1), specifically a -2.9% decline in FEV(1) (95% CI: -5.0, -0.9) per 1-log increase in elastase. Although correlated with FEV(1), bacterial densities were unable to explain clinically meaningful differences in FEV(1) within and across patients.

Conclusions: These data support the role of sputum biomarkers as correlates of disease severity in a diverse CF population.

Citing Articles

Extracellular vesicles in sputum of children with cystic fibrosis pulmonary exacerbations.

Ben-Meir E, Antounians L, Eisha S, Ratjen F, Zani A, Grasemann H ERJ Open Res. 2024; 10(6).

PMID: 39655173 PMC: 11626615. DOI: 10.1183/23120541.00547-2024.

Targeting neutrophil serine proteases in bronchiectasis.

Chalmers J, Mall M, Chotirmall S, ODonnell A, Flume P, Hasegawa N Eur Respir J. 2024; 65(1).

PMID: 39467608 PMC: 11694565. DOI: 10.1183/13993003.01050-2024.

Neutrophil serine proteases in cystic fibrosis: role in disease pathogenesis and rationale as a therapeutic target.

Mall M, Davies J, Donaldson S, Jain R, Chalmers J, Shteinberg M Eur Respir Rev. 2024; 33(173).

PMID: 39293854 PMC: 11409056. DOI: 10.1183/16000617.0001-2024.

Localized Surface Plasmon Resonance Sensing and its Interplay with Fluidics.

Bhalla N, Shen A Langmuir. 2024; 40(19):9842-9854.

PMID: 38684953 PMC: 11100005. DOI: 10.1021/acs.langmuir.4c00374.

Mucus Structure, Viscoelastic Properties, and Composition in Chronic Respiratory Diseases.

Abrami M, Biasin A, Tescione F, Tierno D, Dapas B, Carbone A Int J Mol Sci. 2024; 25(3).

PMID: 38339210 PMC: 10856136. DOI: 10.3390/ijms25031933.

References

Henig N, Tonelli M, Pier M, Burns J, Aitken M . Sputum induction as a research tool for sampling the airways of subjects with cystic fibrosis. Thorax. 2001; 56(4):306-11. PMC: 1746031. DOI: 10.1136/thorax.56.4.306. View

Chmiel J, Berger M, Konstan M . The role of inflammation in the pathophysiology of CF lung disease. Clin Rev Allergy Immunol. 2002; 23(1):5-27. DOI: 10.1385/CRIAI:23:1:005. View

Ordonez C, Stulbarg M, Grundland H, Liu J, Boushey H . Effect of clarithromycin on airway obstruction and inflammatory markers in induced sputum in cystic fibrosis: a pilot study. Pediatr Pulmonol. 2001; 32(1):29-37. DOI: 10.1002/ppul.1085. View

Sagel S, Kapsner R, Osberg I, Sontag M, Accurso F . Airway inflammation in children with cystic fibrosis and healthy children assessed by sputum induction. Am J Respir Crit Care Med. 2001; 164(8 Pt 1):1425-31. DOI: 10.1164/ajrccm.164.8.2104075. View

Sagel S, Sontag M, Wagener J, Kapsner R, Osberg I, Accurso F . Induced sputum inflammatory measures correlate with lung function in children with cystic fibrosis. J Pediatr. 2002; 141(6):811-7. DOI: 10.1067/mpd.2002.129847. View

Mayer-Hamblett N, Rosenfeld M, Emerson J, Goss C, Aitken M . Developing cystic fibrosis lung transplant referral criteria using predictors of 2-year mortality. Am J Respir Crit Care Med. 2002; 166(12 Pt 1):1550-5. DOI: 10.1164/rccm.200202-087OC. View

Saiman L, Marshall B, Mayer-Hamblett N, Burns J, Quittner A, Cibene D . Azithromycin in patients with cystic fibrosis chronically infected with Pseudomonas aeruginosa: a randomized controlled trial. JAMA. 2003; 290(13):1749-56. DOI: 10.1001/jama.290.13.1749. View

Sagel S . Noninvasive biomarkers of airway inflammation in cystic fibrosis. Curr Opin Pulm Med. 2003; 9(6):516-21. DOI: 10.1097/00063198-200311000-00012. View

Gibson R, Burns J, Ramsey B . Pathophysiology and management of pulmonary infections in cystic fibrosis. Am J Respir Crit Care Med. 2003; 168(8):918-51. DOI: 10.1164/rccm.200304-505SO. View

10.

Ordonez C, Henig N, Mayer-Hamblett N, Accurso F, Burns J, Chmiel J . Inflammatory and microbiologic markers in induced sputum after intravenous antibiotics in cystic fibrosis. Am J Respir Crit Care Med. 2003; 168(12):1471-5. DOI: 10.1164/rccm.200306-731OC. View

11.

Moss R, Rodman D, Terry Spencer L, Aitken M, Zeitlin P, Waltz D . Repeated adeno-associated virus serotype 2 aerosol-mediated cystic fibrosis transmembrane regulator gene transfer to the lungs of patients with cystic fibrosis: a multicenter, double-blind, placebo-controlled trial. Chest. 2004; 125(2):509-21. DOI: 10.1378/chest.125.2.509. View

12.

KNUDSON R, LEBOWITZ M, Holberg C, Burrows B . Changes in the normal maximal expiratory flow-volume curve with growth and aging. Am Rev Respir Dis. 1983; 127(6):725-34. DOI: 10.1164/arrd.1983.127.6.725. View

13.

Nixon P, Orenstein D, Kelsey S, DOERSHUK C . The prognostic value of exercise testing in patients with cystic fibrosis. N Engl J Med. 1992; 327(25):1785-8. DOI: 10.1056/NEJM199212173272504. View

14.

Ramsey B, Boat T . Outcome measures for clinical trials in cystic fibrosis. Summary of a Cystic Fibrosis Foundation consensus conference. J Pediatr. 1994; 124(2):177-92. DOI: 10.1016/s0022-3476(94)70301-9. View

15.

Konstan M, Hilliard K, Norvell T, Berger M . Bronchoalveolar lavage findings in cystic fibrosis patients with stable, clinically mild lung disease suggest ongoing infection and inflammation. Am J Respir Crit Care Med. 1994; 150(2):448-54. DOI: 10.1164/ajrccm.150.2.8049828. View

16.

Demko C, Byard P, DAVIS P . Gender differences in cystic fibrosis: Pseudomonas aeruginosa infection. J Clin Epidemiol. 1995; 48(8):1041-9. DOI: 10.1016/0895-4356(94)00230-n. View

17.

Yanez 3rd N, Kronmal R, Shemanski L . The effects of measurement error in response variables and tests of association of explanatory variables in change models. Stat Med. 1998; 17(22):2597-606. DOI: 10.1002/(sici)1097-0258(19981130)17:22<2597::aid-sim940>3.0.co;2-g. View

18.

Moss R, Mayer-Hamblett N, Wagener J, Daines C, Hale K, Ahrens R . Randomized, double-blind, placebo-controlled, dose-escalating study of aerosolized interferon gamma-1b in patients with mild to moderate cystic fibrosis lung disease. Pediatr Pulmonol. 2004; 39(3):209-18. DOI: 10.1002/ppul.20152. View

19.

Sagel S, Kapsner R, Osberg I . Induced sputum matrix metalloproteinase-9 correlates with lung function and airway inflammation in children with cystic fibrosis. Pediatr Pulmonol. 2005; 39(3):224-32. DOI: 10.1002/ppul.20165. View

20.

Belkin R, Henig N, Singer L, Chaparro C, Rubenstein R, Xie S . Risk factors for death of patients with cystic fibrosis awaiting lung transplantation. Am J Respir Crit Care Med. 2006; 173(6):659-66. PMC: 2662949. DOI: 10.1164/rccm.200410-1369OC. View